Social Media Newsroom

About

Enzolytics Inc. is a Texas-based biotechnology company that focuses on therapeutics to treat numerous human health medical conditions. In addition to Enzolytics IPF Immune™, which will be on the U.S. market soon, the Company is developing other therapeutics for treating multiple infectious diseases.

Connect

Press Contact

Name
Robert Grant
Phone
5615440719
Email
Contact Us
Website
https://inhealthmedia.com/

Press Releases

Enzolytics’ IPF Immune™ Nutritional Supplement is Now Live on Amazon and Walmart.com

More Released on April 19, 2023

Enzolytics’ IPF Immune™ Nutritional Supplement is Now Live on Walmart.com

More Released on April 6, 2023

Enzolytics’s IPF Immune™ Nutritional Supplement is Live on Amazon

More Released on March 30, 2023

Enzolytics’s IPF Immune™ Supports the Natural Function of the Immune System

More Released on March 21, 2023

Enzolytics’ IPF Immune™ Dietary Helps Boost the Body’s Self-Defense System

More Released on March 9, 2023

Enzolytics CEO: Global Immune Health Supplement Sector Expects 11.3 Percent Growth through 2028

More Released on March 6, 2023

Enzolytics’s IPF Immune™ Dietary Supplement Will Soon Go Live on Amazon

More Released on February 23, 2023

Biotech Company Develops IPF Immune™ Dietary Supplement Which Supports the Body’s Natural Immune Function

More Released on February 15, 2023

Enzolytics’ IPF Immune™ Provides a Comprehensive Natural Solution for Supporting Normal Immune Function

More Released on February 6, 2023

Enzolytics Inc. CEO: Popularity of Immune Boosters Have Increased with Consumers

More Released on January 12, 2023

Walmart.com Will Soon Offer Enzolytics’s IPF Immune™ Nutritional Supplement

More Released on January 6, 2023

Enzolytics Inc. CEO: Getting Healthy is an Important New Year’s Resolution

More Released on December 30, 2022

OneLavi.com Now Offers Enzolytics’ IPF Immune™ Nutritional Supplement

More Released on December 22, 2022

Enzolytics Inc. CEO: Global Immune Health Supplement Market Expected to Grow from $20 Billion in 2020 to $31.5 Billion in 2028

More Released on December 6, 2022

Enzolytics’ IPF Immune™ Supports the Body’s Self-Defense System

More Released on November 8, 2022

Enzolytics Meets With Major Retailers at Recent ECRM Event

More Released on October 10, 2022

Enzolytics Meets With Major Retailers at Recent ECRM Event

More Released on October 7, 2022

Enzolytics Will Promote its Nutritional Supplement at ECRM Event Next Week

More Released on September 8, 2022

Enzolytics Inc.: A Texas-Based Biotech Company Dedicated to Developing Therapeutics to Treat Infectious Diseases

More Released on May 20, 2022

Enzolytics CEO: Immune Modulator Stimulates the Immune System

More Released on April 29, 2022

Enzolytics CEO: Immune Health Supplements Market Expected to Increase by 9 Percent Annually Through 2031

More Released on April 21, 2022

Enzolytics, Inc. Continues Product Launch of Immune Modulator After Meeting With Retailers

More Released on April 19, 2022

OneLavi.com Will Soon Offer Enzolytics IPF Immune™

More Released on April 11, 2022

CEO of Enzolytics IPF Immune™: CRN Data Shows Record-Breaking Number of Americans Use Dietary Supplements

More Released on March 29, 2022

CEO of Enzolytics IPF Immune™: Tips to Boost Your Immune System

More Released on March 25, 2022

Enzolytics IPF Immune™ Plans Debut at ECRM’s "Weight Management, Nutrition, and Vitamin Program"

More Released on February 28, 2022

Enzolytics CEO: Consumers Actively Searching For Immune Booster Supplements

More Released on February 24, 2022

Enzolytics IPF Immune™ is the Perfect Choice for People With Weakened Immune Systems

More Released on February 16, 2022